NEW YORK (GenomeWeb) – Trovagene said today that it has signed new distribution agreements for its Trovera liquid biopsy tests with seven companies across Europe and the Middle East.

These new strategic partners include Alliance Global for the Middle East, Africa, and Central and South Asia; Instituto Diagnostico and Sorgente Genetica Varelli in Italy; Progenetics in Israel; Amplitech in France, Belgium, and Switzerland; NM Genomix for Bulgaria and Eastern Europe; and Diagnostica Longwood in Spain and Portugal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.